Estropipate combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 1/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/12/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/11/2003 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/16/2000 58 Female 160 lb 12/23/2005 United States
Primary
Secondary
Metastasis Other Serious Female 2/21/2006 Lawyer United States
Primary
Secondary
Metastases To Peripheral Vascular System Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/24/2000 Female 3/2/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/17/2000 57 Female 3/23/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2001 Female 4/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/1/2004 66 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2000 Female 7/5/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 7/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/30/2002 Female 10/17/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/30/2002 Female 10/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/24/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2003 60 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 4/17/2000 63 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2003 53 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/26/2002 68 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 9/4/2003 Female 125 lb 2/2/2007 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 198 lb 3/28/2007 United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Other Serious 12/23/1992 63 Female 124 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Breast Operation Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/24/2000 Female 12/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 64 Female 12/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/9/2002 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/16/2000 58 Female 160 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 65 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/13/2004 50 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 4/18/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/9/2001 Female 7/6/2007 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 9/24/2002 Female 6/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/7/2003 Female 10/16/2007 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/1/2002 61 Female 190 lb 11/3/2007 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 9/24/2002 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2002 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 12/12/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/15/2000 65 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 3/17/2004 57 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2001 61 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 4/19/2000 44 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/31/2002 Female 2/8/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/1/2003 Female 2/14/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2002 Female 2/27/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/6/2001 Female 3/3/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Endometriosis Other Serious 7/17/1986 Female 3/25/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/6/2003 Female 3/31/2008 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/13/1998 Female 3/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/6/2001 Female 4/10/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 5/8/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death Female 6/25/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 7/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death 1/1/1997 Female 7/24/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 60 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/24/2000 63 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/6/2002 63 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/25/2003 68 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 4/17/2000 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2003 53 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 67 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/2/1999 Female 12/23/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/6/2000 Female 12/23/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/11/2002 73 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/18/2001 62 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/5/1999 57 Female 12/19/2008 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/4/2000 54 Female 12/19/2008 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/6/2004 76 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/13/2004 50 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/5/2001 55 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/12/2000 59 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/12/2001 53 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2003 65 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/17/2000 66 Female 12/19/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 64 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/17/2000 75 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/14/2001 57 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/16/2000 58 Female 160 lb 12/19/2008 United States
Primary
Secondary
Renal Failure Acute Hospitalization 8/21/2008 63 Female 152 lb 2/25/2009 United States
Primary
Concomitant
Breast Cancer Metastatic Other Serious 3/1/2003 Female 3/13/2009 Lawyer United States
Primary
Secondary
Ureteric Injury Other Serious 9/24/2002 Female 134 lb 3/24/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/26/2002 Female 137 lb 3/25/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2000 Female 130 lb 3/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/5/2001 Female 152 lb 3/27/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/17/2000 Female 4/3/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/24/2003 Female 141 lb 4/21/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/20/2002 Female 137 lb 4/22/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/11/2003 Female 200 lb 5/12/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/17/2000 Female 5/12/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 5/19/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/24/2000 Female 220 lb 5/20/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 Female 139 lb 5/25/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/30/2002 Female 141 lb 5/28/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/22/2003 69 Female 120 lb 5/19/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/2003 Female 6/5/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/20/2000 Female 6/23/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2000 Female 7/2/2009 Lawyer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2000 Female 7/6/2009 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/1/1998 Female 154 lb 7/13/2009 Lawyer United States
Primary
Secondary
Scleroderma Other Serious 12/1/2001 Female 8/4/2009 Consumer United States
Primary
Secondary
Scleroderma Other Serious 12/1/2001 Female 8/7/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/17/2002 Female 209 lb 8/19/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/20/2002 Female 137 lb 8/26/2009 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2000 Female 8/27/2009 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 8/14/2003 Female 8/28/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 9/19/2009 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2000 Female 145 lb 11/30/2009 United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 12/1/2001 Female 12/4/2009 Consumer United States
Primary
Secondary
Treatment Failure Hospitalization 1/1/2002 60 Female 186 lb 10/21/2009 Physician United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/19/2000 Female 145 lb 1/28/2010 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2009 50 Female 100 lb 4/23/2010 Physician United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2009 50 Female 100 lb 5/14/2010 Physician United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/19/2000 54 Female 145 lb 5/20/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 5/21/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 5/24/2010 Consumer United States
Primary
Secondary
Muscle Spasms Other Serious 1/1/2010 74 Female 127 lb 5/25/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 5/24/2010 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2009 50 Female 100 lb 5/27/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/22/2003 69 Female 120 lb 5/19/2010 Consumer United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 1/1/2006 60 Female 119 lb 5/19/2010 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2009 50 Female 100 lb 6/2/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/1/1998 47 Female 289 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 6/4/2010 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2001 52 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/14/2004 65 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/17/2002 62 Female 150 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Muscle Spasms Other Serious 1/1/2010 74 Female 127 lb 6/23/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/14/2003 62 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/10/2000 48 Female 119 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/10/2000 48 Female 119 lb 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2003 52 Female 150 lb 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/14/2004 65 Female 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2001 52 Female 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/5/1999 57 Female 190 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 6/25/2010 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 63 Female 198 lb 4/5/2010 United States
Primary
Secondary
Scleroderma Other Serious 1/1/2006 60 Female 119 lb 5/19/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/14/2008 64 Female 5/19/2010 Consumer United States
Primary
Secondary

Drug Data